Facilitated By

San Antonio Medical Foundation

SwRI AWARDED $1.9 MILLION CONTRACT TO DEVELOP TREATMENT FOR COVID-19 IN COLLABORATION WITH DOD

Southwest Research Institute

Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.

Principal Investigator(s)
Dr. Jonathan Bohmann
Collaborating Institutions
U.S. Army Medical Research Institute of Infectious Diseases
Texas Biomedical Research Institute
Walter Reed Army Institute of Research
Funded by
U.S. Department of Defense, U.S. Army Medical Research Acquisition Activity
Research Start Date
Status
Active

Using Department of Defense supercomputers, Southwest Research Institute is virtually screening millions of drug compounds to search for and test possible treatment options for the novel coronavirus 2019. The Henry M. Jackson Foundation for the Advancement of Military Medicine has awarded SwRI a $1.9 million, one-year contract to support efforts to develop a COVID-19 treatment.

SwRI is working with the DOD High Performance Computing Modernization Program to rapidly screen potential drug compounds using SwRI’s 3D drug screening software tool, Rhodium™. Using supercomputers speeds up the screening process allowing evaluation of possible therapeutic compounds to increase from 250,000 compounds a day to more than 40 million compounds in just one week.

Collaborative Project
Basic Research
Disease Modeling
Drug Discovery
Infectious Disease
Cancer
Other